Multiple Sclerosis Information
Search
I would appreciate a donation. I spend a lot of time every day in researching for articles and the latest research on MS. When an something is written in medical terminology I translate it into non-medical terms. I can no longer work because of my MS.
This Month
February 2008
Sun Mon Tue Wed Thu Fri Sat
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29
Main Page  »  Research  »  Research
View Article  Exercise Can Cut Coronary Artery Disease Risk For Some With Multiple Sclerosis
Results of a study suggest that people with mild to moderate multiple sclerosis (MS) are capable of improving their aerobic fitness levels similar to their non-MS counterparts. While physical inactivity may    more »
View Article  Natalizumab Has Benefits on Disability
natalizumab results in significant improvements in scores on health-related quality of life (QoL) questionnaires in patients    more »
View Article  New Insights and Trends
The past few years have witnessed major advancements in our ability to diagnose multiple sclerosis (MS) and begin treatments that can favourably modify the course of the disease. In addition, there is now a much better understanding of the pathogenesis of the disease and an increasing interest in “decoding” the    more »
View Article  Disease Severity, Sociodemographic Factors May Influence Mental Function, Motor Function Among Patients With MS
Among individuals with MS, the extent of mental and physical functioning appears to be affected by the sociodemographic factors, such as education level, and the severity of MS, a study published    more »
View Article  MS in Genetically Susceptible Twins
A new study of twins suggests that living farther north of the equator significantly increases risk of developing Multiple Sclerosis (MS) among those with genetic    more »
View Article  New therapeutic target for the treatment of multiple sclerosis
A study published in the February issue of Nature Immunology provides answers about the role of novel adhesion molecules in the pathogenesis of multiple sclerosis (MS) and suggests   more »
View Article  No Differences Found Between Betaseron and Copasone for MS

No Differences Found Between Interferon Beta-1b and Glatiramer for Multiple Sclerosis:

 

Presented at ECTRIMS


 
PRAGUE, CZECH REPUBLIC –

Treatment with interferon beta-1b (IFNbeta-1b) ...   more »

View Article  Three Genomic Markers Correlate With Multiple Sclerosis:

Three Genomic Markers Correlate With Multiple Sclerosis:

 

Three gene variants have been found to correlate with susceptibility to multiple sclerosis, according to findings of ...   more »

View Article  Minocycline Has Harmful Effect on Patients With Motor Neuron Disease

Minocycline Has Harmful Effect on Patients With Motor Neuron Disease

 

LONDON, U.K. –

 

Minocycline has a harmful effect on patients with amyotrophic lateral ...   more »

View Article  Study: Copaxone verses Rebif for relapse rate and cost

Study Showed Patients Using COPAXONE® Had Significantly Lower Risk of Relapse and Lower Medical Costs Compared to Patients Using Rebif® in Relapsing-Remitting Multiple ...   more »

View Article  Tysabri (natalizumab) – study how Tysabri effects quality of life in multiple sclerosis

Tysabri (natalizumab) – study how Tysabri effects quality of life in multiple sclerosis


Department of Neurology,

Mellen Center for Multiple Sclerosis Treatment and Research,

Cleveland ...   more »

View Article  Stem Cell Therapies- International Distribution System

Vavici Announces Formation of First Comprehensive International Distribution System for Stem Cell Therapies

NEW YORK--(BUSINESS WIRE)—

 

Vavici has announced its plans to create ...   more »

View Article  Tysabri - when stopping using there is increase disease activity

Disease Activity Increases After MS Patients Stop Natalizumab (Tysabri) Treatment

 

ST. PAUL, MN -- September 12, 2007 -- People with multiple sclerosis (MS) who ...   more »

View Article  Disease Benefit with HE3286 in Model of Multiple Sclerosis



Disease Benefit with HE3286 in Model of Multiple Sclerosis Highlighted at 2nd International Congress on Immune-Mediated Diseases


Hollis-Eden Pharmaceuticals Reports on Anti-Inflammatory Activity with HE3286 ...   more »

View Article  VITAMIN D SUPPLEMENTS

VITAMIN D SUPPLEMENTS APPEAR TO BE ASSOCIATED WITH LOWER RISK OF DEATH

CHICAGO—Individuals who take vitamin D supplements appear to have a lower risk of ...   more »